OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
161890$97100.0059

Kolmar Korea Co Ltd

Personal ProductsVerified

Kolmar Korea's capital structure is characterized by a debt-to-equity ratio of 1.35, indicating a moderate reliance on debt financing. The company's liquidity position is weak, with cash and equivalents amounting to only 1.19 billion KRW, which is significantly lower than its long-term debt of 1.23 trillion KRW. The current ratio of 0.74 suggests that the company may struggle to meet its short-term obligations with its current assets. Profitability metrics show that Kolmar Korea's return on equity (ROE) is 13.74%, which is relatively strong, but its return on assets (ROA) is only 3.62%, indicating that the company is not efficiently utilizing its assets to generate returns. The gross profit margin is 29.07%, and the operating margin is 8.72%, both of which are in line with industry norms for personal care products. The company's revenue is distributed across three segments: Cosmetics, Pharmaceutical, and Food. The Cosmetics segment is the primary revenue driver, with the Pharmaceutical and Food segments contributing to a lesser extent. Geographically, the company operates in both domestic and overseas markets, though the exact distribution of revenue by region is not disclosed. Kolmar Korea's growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. The company's revenue history shows a stable but not explosive growth pattern, which is typical for a company in the personal care products industry. Risk factors for Kolmar Korea include a medium liquidity risk, as indicated by the negative net cash position after subtracting total debt. The dilution risk is low, with no significant dilution potential reported. The company's risk assessment also highlights the need for careful monitoring of its debt levels and liquidity position. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's recent financial performance and risk profile remain consistent with its historical trends.

30-day price · 161890+21000.00 (+27.6%)
Low$74000.00High$106200.00Close$97100.00As of15 May, 00:00 UTC
Profile
CompanyKolmar Korea Co Ltd
Ticker161890.KS
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Kolmar Korea Co Ltd is a Korea-based company engaged in the manufacture and distribution of cosmetics, pharmaceuticals, and health functional food, operating through three segments: Cosmetics, Pharmaceutical, and Food.

Classification. Kolmar Korea is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a confidence level of 0.92.

Kolmar Korea's capital structure is characterized by a debt-to-equity ratio of 1.35, indicating a moderate reliance on debt financing. The company's liquidity position is weak, with cash and equivalents amounting to only 1.19 billion KRW, which is significantly lower than its long-term debt of 1.23 trillion KRW. The current ratio of 0.74 suggests that the company may struggle to meet its short-term obligations with its current assets. Profitability metrics show that Kolmar Korea's return on equity (ROE) is 13.74%, which is relatively strong, but its return on assets (ROA) is only 3.62%, indicating that the company is not efficiently utilizing its assets to generate returns. The gross profit margin is 29.07%, and the operating margin is 8.72%, both of which are in line with industry norms for personal care products. The company's revenue is distributed across three segments: Cosmetics, Pharmaceutical, and Food. The Cosmetics segment is the primary revenue driver, with the Pharmaceutical and Food segments contributing to a lesser extent. Geographically, the company operates in both domestic and overseas markets, though the exact distribution of revenue by region is not disclosed. Kolmar Korea's growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. The company's revenue history shows a stable but not explosive growth pattern, which is typical for a company in the personal care products industry. Risk factors for Kolmar Korea include a medium liquidity risk, as indicated by the negative net cash position after subtracting total debt. The dilution risk is low, with no significant dilution potential reported. The company's risk assessment also highlights the need for careful monitoring of its debt levels and liquidity position. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's recent financial performance and risk profile remain consistent with its historical trends.
Key takeaways
  • Kolmar Korea has a strong ROE of 13.74% but a weak ROA of 3.62%, indicating inefficiency in asset utilization.
  • The company's liquidity position is weak, with a current ratio of 0.74 and a negative net cash position.
  • Kolmar Korea's debt-to-equity ratio of 1.35 suggests a moderate reliance on debt financing.
  • The company's revenue is distributed across three segments, with the Cosmetics segment being the primary driver.
  • Analysts have a generally positive outlook, with a mean price target of 99,368.42 KRW and a mean recommendation of 1.67.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$2.72T
Gross profit$791.45B
Operating income$237.46B
Net income$125.08B
R&D
SG&A
D&A
SBC
Operating cash flow$291.43B
CapEx-$179.74B
Free cash flow$68.82B
Total assets$3.46T
Total liabilities$2.55T
Total equity$910.36B
Cash & equivalents$1.2M
Long-term debt$1.23T
Valuation
Market price$97100.00
Market cap$2.29T
Enterprise value$3.52T
P/E18.3
Reported non-GAAP P/E
EV/Revenue1.3
EV/Op income14.8
EV/OCF12.1
P/B2.5
P/Tangible book2.5
Tangible book$910.36B
Net cash-$1.23T
Current ratio0.7
Debt/Equity1.4
ROA3.6%
ROE13.7%
Cash conversion2.3%
CapEx/Revenue-6.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric161890Activity
Op margin8.7%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin4.6%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin29.1%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-6.6%-2.3% medp25 -4.4% · p75 -1.1%bottom quartile
Debt / equity135.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean price target99,368.42 KRW
Median price target98,000.00 KRW
High price target130,000.00 KRW
Low price target76,000.00 KRW
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count9.00
Buy count14.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate6,136.48 KRW
Last actual EPS5,299.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 22:06 UTC#16306e67
Market quoteclose KRW 97100.00 · shares 0.02B diluted
no public URL
2026-05-15 22:08 UTC#7a9a6b76
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 22:09 UTCJob: ce8f8291